• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The association of cytosol oestrogen and progesterone receptors with histological features of breast cancer and early recurrence of disease.细胞质雌激素和孕激素受体与乳腺癌组织学特征及疾病早期复发的关联。
Br J Cancer. 1983 May;47(5):629-40. doi: 10.1038/bjc.1983.101.
2
The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast.雌激素和孕激素受体对乳腺癌患者复发及生存的影响。
Br J Cancer. 1985 Feb;51(2):263-70. doi: 10.1038/bjc.1985.38.
3
[Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].[雌激素受体、孕激素受体及人表皮生长因子受体-2在接受乳房切除术的淋巴结阳性乳腺癌患者中的预后价值]
Zhonghua Zhong Liu Za Zhi. 2010 Jul;32(7):520-5.
4
Tumour cellularity, oestrogen receptors and prognosis in breast cancer.
Clin Oncol. 1983 Dec;9(4):311-8.
5
The oestrogen-progesterone receptor ratio: an indicator of breast cancer evolution.雌激素-孕激素受体比值:乳腺癌进展的一个指标。
Chir Ital. 2002 Jul-Aug;54(4):423-8.
6
Histological differentiation in human breast cancer is related to steroid receptors and stromal elastosis.人类乳腺癌的组织学分化与类固醇受体及间质弹性组织变性有关。
Cancer Chemother Pharmacol. 1980;5(2):73-7. doi: 10.1007/BF00435407.
7
Steroid-hormone receptors and survival after first relapse in breast cancer.类固醇激素受体与乳腺癌首次复发后的生存情况
Lancet. 1984 Mar 17;1(8377):588-91. doi: 10.1016/s0140-6736(84)90995-4.
8
LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.LEA-135表达:其与淋巴结阳性原发性浸润性乳腺癌患者较低的复发风险及总生存期延长的相关性。
Anticancer Res. 2004 Jul-Aug;24(4):2391-400.
9
Androgen receptor activity in human breast cancer and its relationship with oestrogen and progestogen receptor activity.雄激素受体活性在人类乳腺癌中的情况及其与雌激素和孕激素受体活性的关系。
Eur J Cancer Clin Oncol. 1985 Apr;21(4):539-42. doi: 10.1016/0277-5379(85)90049-5.
10
Oestrogen receptor assay and morphology of breast cancer.
Pathology. 1981 Apr;13(2):317-25. doi: 10.3109/00313028109081671.

引用本文的文献

1
Analysis of molecular markers as predictive factors of lymph node involvement in breast carcinoma.分析分子标志物作为乳腺癌淋巴结受累的预测因素
Oncol Lett. 2017 Jan;13(1):488-496. doi: 10.3892/ol.2016.5438. Epub 2016 Nov 28.
2
Correlation of Hormone Receptor Expression with Histologic Parameters in Benign and Malignant Breast Tumors.良性和恶性乳腺肿瘤中激素受体表达与组织学参数的相关性
Iran J Pathol. 2015 Winter;10(1):23-34.
3
Predictive value of pathological and immunohistochemical parameters for axillary lymph node metastasis in breast carcinoma.乳腺癌腋窝淋巴结转移的病理和免疫组织化学参数的预测价值。
Diagn Pathol. 2011 Mar 13;6:18. doi: 10.1186/1746-1596-6-18.
4
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.乳腺癌的基因表达模式可区分具有临床意义的肿瘤亚类。
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74. doi: 10.1073/pnas.191367098.
5
Relation of elastosis to biochemical and immunohistochemical steroid receptor findings, Ki-67 and epidermal growth factor receptor (EGFR) immunostaining in invasive ductal breast cancer.
Virchows Arch A Pathol Anat Histopathol. 1993;422(4):319-26. doi: 10.1007/BF01608342.
6
Oestrogen and progesterone receptors and disease-free interval in primary breast cancer.原发性乳腺癌中的雌激素和孕激素受体与无病生存期
Br J Cancer. 1984 Nov;50(5):667-72. doi: 10.1038/bjc.1984.234.
7
Practical breast carcinoma cell kinetics: review and update.实用的乳腺癌细胞动力学:综述与更新
Breast Cancer Res Treat. 1984;4(2):79-88. doi: 10.1007/BF01806389.
8
Disease-free interval and estrogen receptor activity in tumor tissue of patients with primary breast cancer: analysis after long-term follow-up.原发性乳腺癌患者肿瘤组织中的无病生存期和雌激素受体活性:长期随访后的分析
Breast Cancer Res Treat. 1985;6(2):123-30. doi: 10.1007/BF02235743.
9
The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast.雌激素和孕激素受体对乳腺癌患者复发及生存的影响。
Br J Cancer. 1985 Feb;51(2):263-70. doi: 10.1038/bjc.1985.38.
10
Breast cancer prognosis in three different racial groups in relation to steroid hormone receptor status.
Breast Cancer Res Treat. 1986;7(2):111-8. doi: 10.1007/BF01806796.

本文引用的文献

1
Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.乳腺癌的组织学分级与预后;对1409例病例的研究,其中359例已随访15年。
Br J Cancer. 1957 Sep;11(3):359-77. doi: 10.1038/bjc.1957.43.
2
Histological differentiation in human breast cancer is related to steroid receptors and stromal elastosis.人类乳腺癌的组织学分化与类固醇受体及间质弹性组织变性有关。
Cancer Chemother Pharmacol. 1980;5(2):73-7. doi: 10.1007/BF00435407.
3
The clinical value of multiple steroid receptor assays in breast cancer management.多种类固醇受体检测在乳腺癌管理中的临床价值。
Cancer. 1980 Dec 15;46(12 Suppl):2939-45. doi: 10.1002/1097-0142(19801215)46:12+<2939::aid-cncr2820461440>3.0.co;2-5.
4
Relationship of presence of progesterone receptors to prognosis in early breast cancer.早期乳腺癌中孕激素受体的存在与预后的关系。
Cancer Res. 1980 Sep;40(9):3357-60.
5
Possible test for selection of adjuvant systemic therapy in early cancer of the breast.早期乳腺癌辅助全身治疗选择的可能检测方法。
Br J Surg. 1980 Oct;67(10):747-50. doi: 10.1002/bjs.1800671018.
6
The relative importance of estrogen receptor analysis as a prognostic factor for recurrence or response to chemotherapy in women with breast cancer.雌激素受体分析作为乳腺癌女性复发或化疗反应的预后因素的相对重要性。
Cancer. 1980 Apr 15;45(8):1993-2000. doi: 10.1002/1097-0142(19800415)45:8<1993::aid-cncr2820450802>3.0.co;2-2.
7
Histopathological characteristics and oestrogen receptor content in primary breast carcinoma.原发性乳腺癌的组织病理学特征及雌激素受体含量
Virchows Arch A Pathol Anat Histol. 1981;390(3):347-51. doi: 10.1007/BF00496564.
8
Estrogen receptor protein in breast cancer as a predictor of recurrence.乳腺癌中的雌激素受体蛋白作为复发的预测指标。
Cancer. 1981 May 15;47(10):2364-7. doi: 10.1002/1097-0142(19810515)47:10<2364::aid-cncr2820471007>3.0.co;2-s.
9
Estrogen receptor level and other factors in early recurrence of breast cancer.雌激素受体水平及其他因素与乳腺癌早期复发的关系
Int J Cancer. 1980 Oct 15;26(4):429-33. doi: 10.1002/ijc.2910260407.
10
Oestrogen receptor values and histological grade in human breast cancer.
Histopathology. 1981 May;5(3):257-62. doi: 10.1111/j.1365-2559.1981.tb01784.x.

细胞质雌激素和孕激素受体与乳腺癌组织学特征及疾病早期复发的关联。

The association of cytosol oestrogen and progesterone receptors with histological features of breast cancer and early recurrence of disease.

作者信息

Howat J M, Barnes D M, Harris M, Swindell R

出版信息

Br J Cancer. 1983 May;47(5):629-40. doi: 10.1038/bjc.1983.101.

DOI:10.1038/bjc.1983.101
PMID:6849801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2011376/
Abstract

Two hundred and eighty-eight primary breast tumours were examined for the presence or absence of oestrogen (REc) and progesterone (RPc) receptors. Analysis has shown a relative interdependence between the steroid receptor status of primary breast cancer and other prognostic variables such as histological grade, lymphocytic infiltration and tumour elastosis. There were significant associations between epithelial cellularity, stromal fibrosis and the value of REc in those tumours in which the receptor was present. Cellularity and fibrosis were unrelated to the presence or absence of oestrogen receptor. By contrast, neither the presence or absence nor the value of RPc could be related to cellularity or fibrosis. The value of REc and RPc analysis as an indicator of prognosis was examined in a sub-group of 175 patients receiving no additional treatment following mastectomy. Overall relapse-free survival (RFS) was no different for those patients with receptors compared to those without them (REc P = 0.11, RPc P = 0.7). There was no difference in RFS of receptor positive and negative tumours when the axillary node status was taken into account.

摘要

对288例原发性乳腺肿瘤进行了雌激素(REc)和孕激素(RPc)受体的检测,以确定其是否存在。分析表明,原发性乳腺癌的类固醇受体状态与其他预后变量之间存在相对的相互依赖性,如组织学分级、淋巴细胞浸润和肿瘤弹性组织变性。在那些存在受体的肿瘤中,上皮细胞密度、间质纤维化与REc值之间存在显著关联。细胞密度和纤维化与雌激素受体的存在与否无关。相比之下,RPc的存在与否及其值均与细胞密度或纤维化无关。在175例乳房切除术后未接受额外治疗的患者亚组中,研究了REc和RPc分析作为预后指标的价值。有受体的患者与无受体的患者相比,总体无复发生存期(RFS)无差异(REc P = 0.11,RPc P = 0.7)。当考虑腋窝淋巴结状态时,受体阳性和阴性肿瘤的RFS没有差异。